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Reliability of the Modified Rankin Scale
To the Editor:
We read with interest the review of the modified Rankin Scale
(mRS) by Banks and Marotta.1 Although not developed as a trial
end point, mRS is now the preferred disability outcome measure
in stroke trials, and discussion of the scale and its clinimetric
properties is timely and valuable. Several points raised are
worthy of further consideration.
Accurate quantification of test-retest reliability for clinical
scales is challenging. Testing intraobserver variability over a
short time period will be biased by observer recall of previous
grading; delaying second testing allows for potentially signifi-
cant patient improvement or disease progression. We should be
cautious in extrapolating the results of studies that have reported
acceptable intraobserver reliability of mRS2,3 because both
studies used a maximum delay of 2 weeks between gradings.
Assuming a consistent approach is used, video recording of the
mRS interview for later review should be less prone to such bias.
We are currently analyzing data from a project that used this
design.4
Interobserver variability of mRS has been extensively studied
and the authors provide a succinct review; however, again we
must exercise caution in interpretation of the positive results
reported. The majority of published studies testing interobserver
variability have limited their observers to a few or even one
individual, of similar background training from a single center.3
Country of origin5 and background training of assessor6 both
influence mRS grading. Thus, to test reliability of mRS across
multiple raters robustly requires a range of international centers,
mimicking a large scale clinical trial. Studies using this approach
show disappointing agreement in standard mRS grading
(k0.25).3
Reliability of mRS is of more than clinimetric interest.
Misclassification of mRS will increase type II error rate and
decrease statistical power. The significant effect of misclassifi-
cation of clinical end points has already been described, in one
large scale trial minor variation in classification of cause of death
reduced trial power by 40%.7 Issues of statistical power are of
both ethical and economic importance in stroke medicine where
previous trials have been underpowered to detect modest but
meaningful treatment effects.
Methods to improve the reliability of mRS have been devel-
oped, and we anticipate their increasing use in stroke trial design.
Banks and Marotta discuss the improvements that can be
achieved with a structured mRS interview,3 but we would draw
attention to other methods currently being developed. Training
and certification is now a prerequisite of National Institutes of
Health Stroke Scale (NIHSS) use for clinical trials with resultant
improved reliability.8 A video-based training system for mRS
has been developed and used successfully in 3 large-scale trials
(SAINT I; CHANT; SAINT II)5; further validation is underway.
Shinohara demonstrated a further application of video technol-
ogy, using mRS interview videos to validate a native language
questionnaire.9 Such an approach could be extended to a multi-
center trial setting with central “off-line” assessment of mRS.
Pilot work to further explore the use of such an approach is
ongoing.4
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